Harris Todd 4
4 · Tyra Biosciences, Inc. · Filed Sep 20, 2024
Insider Transaction Report
Form 4
Harris Todd
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-09-19$25.10/sh−27$678→ 1,496,729 total - Sale
Common Stock
2024-09-18$24.00/sh−3,500$84,000→ 1,502,427 total - Sale
Common Stock
2024-09-19$24.30/sh−5,671$137,813→ 1,496,756 total - Sale
Common Stock
2024-09-20$24.19/sh−7,109$171,950→ 1,489,620 total
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.
- [F2]Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $24.00 to $24.9749. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.8963. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.